Vaccine keeps advanced kidney cancer from recurring

Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial, researchers reported in Nature.
New Vaccine Shows Promise For Kidney Cancer
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer three years after the pioneering treatment.
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated robust immune response, according to findings of a new study led by HMS researchers at Dana-Farber Cancer Institute.
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses and keeping patients cancer-free for years.
Experimental vaccine seems to battle advanced kidney cancers
Related Dwyane Wade reveals kidney cancer diagnosis, surgery EPA bans two common solvents linked to cancer VA weighs whether so-called forever chemicals have connection to kidney cancer "We want ...
Neoantigen vaccine sparks powerful immune defense against kidney cancer
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to long-lasting T cell expansion and no disease recurrence after 40 months.
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults. In an early-stage clinical trial led by the Dana-Farber Cancer Institute in Boston,
Immunogenic Cancer Vaccine Targets Key Mutations in Kidney Cancer
Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, according to a study published online Feb.
Boston researchers make progress in kidney cancer vaccine
Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune system to eliminate tumor cells.
Dwyane Wade reveals kidney surgery for cancer diagnosis
Dwyane Wade endured the roughest year of his life in 2024 without telling many people about it. Five years after retiring ...
NBC News on MSN9d
Dwyane Wade reveals he was diagnosed with cancer at 41: ‘Thank God that I did do the surgery’
The tumor couldn’t be biopsied, and surgery was the only way to confirm if it was cancerous. So, on Dec. 18, 2023, Wade had a ...
NBA Hall of Famer Dwyane Wade reveals shocking cancer diagnosis and partial kidney removal
Hall of Famer Dwyane Wade revealed on his podcast that he had been putting off a physical but health concerns prompted a ...
BlackDoctor.org9d
NBA All-Star Dwayne Wade Reveals Kidney Cancer & Surgery
Retired NBA All-star revealed that he had kidney cancer and had to get 40% of his kidney removed after going in for ...
Dwyane Wade reveals kidney cancer diagnosis, surgery
Former NBA All-Star and champion Dwyane Wade on Thursday announced he had 40% of his right kidney removed along with a ...
FOX 5 New York on MSN10d
Dwyane Wade reveals cancer diagnosis, kidney surgery
Wade revealed Thursday that part of one of his kidneys were removed due to a tumor and that he underwent surgery in December ...